Related Experiment Videos
Effects of benoxaprofen on human neutrophil function
The Journal of Rheumatology
|June 1, 1984
Summary
Benoxaprofen partially inhibited human neutrophil phagocytosis and response to chemotactic factors in vitro. High concentrations also enhanced granular enzyme release, suggesting mechanisms for its clinical efficacy and toxicity.
Area of Science:
- Immunology
- Pharmacology
- Cell Biology
Background:
- Neutrophils play a critical role in the immune response.
- Anti-inflammatory drugs can modulate neutrophil function.
- Understanding drug effects on neutrophils is crucial for assessing efficacy and toxicity.
Purpose of the Study:
- To investigate the in vitro effects of benoxaprofen on human neutrophil functions.
- To compare benoxaprofen's effects with those of aspirin and gold.
Main Methods:
- In vitro assays were used to assess neutrophil phagocytosis, adherence, enzyme release, and chemotaxis.
- Human neutrophils were exposed to varying concentrations of benoxaprofen.
Main Results:
- Benoxaprofen partially inhibited phagocytosis at 30 and 300 µg/ml, without affecting adherence.
- High concentrations (300 µg/ml) enhanced beta-glucuronidase and lysozyme release from neutrophils.
- Benoxaprofen inhibited neutrophil response to chemotactic factors at high concentrations.
Conclusions:
- Benoxaprofen exhibits unique in vitro effects on neutrophil functions.
- These findings correlate with clinical reports on benoxaprofen's efficacy and toxicity.
- The study provides insights into the pharmacological mechanisms of benoxaprofen.